A comprehensive genetic study of the proteasomal subunit S6 ATPase in German Parkinson’s disease patients.
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Dysfunction of proteasomal protein degradation is involved in neurodegeneration in Parkinson's disease (PD). Recently we identified the regulatory proteasomal subunit S6 ATPase as a novel interactor of synphilin-1, which is a substrate of the ubiquitin-ligase Parkin (PARK2) and an interacting protein of alpha-synuclein (PARK1). To further investigate a potential role in the pathogenesis of PD, we performed a detailed mutation analysis of the S6 ATPase gene in a large sample of 486 German sporadic and familial PD patients. Direct sequencing revealed two novel intronic variants. An insertion/deletion variant in intron 5 of the S6 ATPase gene was more frequent in patients compared to controls. Moreover, this variant was significantly more frequent in early-onset compared to late-onset PD patients. The identification of a genetic link between a regulatory proteasomal subunit and PD further underscores the relevance of disturbed protein degradation in PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, Rpt3 mutations have been described in patients with Parkinson’s disease (Wahl et al., 2008).”
From Inducible Rpt3, a Proteasome Component, Knockout in Adult Skeletal Muscle Results in Muscle Atrophy (2020) · cites this paper as Wahl et al., 2008
Citations
Cites
GENEPOP (Version 1.2): Population Genetics Software for Exact Tests and Ecumenicism
Raymond, M., & Rousset, F. (1995) · Journal of Heredity · doi:10.1093/oxfordjournals.jhered.a111573 · Cited by 15,397
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 1×
“Subsequently alpha-synuclein was recognized as the major component of Lewy bodies not only in brains of rare mutation carriers, but also in brains of common idiopathic PD patients ( Spillantini et al. 1997 ).”
BackgroundMutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · cited 1×
“These proteins are critically related to the ubiquitin-mediated protein degradation pathway and are mutated in familial forms of PD ( Kitada et al. 1998; Leroy et al. 1998).”
BackgroundSelf-citationThe relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis
Voges, D., Zwickl, P., & Baumeister, W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.1015 · Cited by 1,608 · cited 2×
“The 26S proteasome is a multicatalytic protease complex that is critically involved in efficient removal of misfolded and regulatory proteins whose accumulation is detrimental to neuronal cells ( Voges et al. 1999 ).”
BackgroundThe ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
Ozelius, L. J., Hewett, J. W., Page, C. E., Bressman, S. B., Kramer, P. L., Shalish, C., de Leon, D., Brin, M. F., Raymond, D., Corey, D. P., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-40 · Cited by 1,007 · cited 1×
“The torsin A gene that is mutated in most cases of early onset dystonia (DYT1) encodes an AAA ATPAse as well ( Ozelius et al. 1997 ).”
BackgroundProteasomal function is impaired in substantia nigra in Parkinson’s disease
McNaught, K. S. P., & Jenner, P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01701-8 · Cited by 653
Hazan, J., Fonknechten, N., Mavel, D., Paternotte, C., Samson, D., Artiguenave, F., Davoine, C.-S., Cruaud, C., Dürr, A., Wincker, P., et al. (1999) · Nature Genetics · doi:10.1038/15472 · Cited by 634
Cited by
The role of protein clearance mechanisms in organismal ageing and age-related diseases
Vilchez, D., Saez, I., & Dillin, A. (2014) · Nature Communications · doi:10.1038/ncomms6659 · Cited by 689
Regulation of proteasome activity in health and disease
Schmidt, M., & Finley, D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.012 · Cited by 464
“onset [175].”
The Mechanistic Links Between Proteasome Activity, Aging and Agerelated Diseases
Saez, I., & Vilchez, D. (2014) · Current Genomics · doi:10.2174/138920291501140306113344 · Cited by 325
“In addition, variations in the gene PSMC4/Rpt3 correlate with the age of PD onset in patients [131].”
BackgroundThe Ubiquitin–Proteasome System in Immune Cells
Çetin, G., Klafack, S., Studencka-Turski, M., Krüger, E., & Ebstein, F. (2021) · Biomolecules · doi:10.3390/biom11010060 · Cited by 209
Tashiro, Y., Urushitani, M., Inoue, H., Koike, M., Uchiyama, Y., Komatsu, M., Tanaka, K., Yamazaki, M., Abe, M., Misawa, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417600 · Cited by 194
“Rpt3 is a subunit of 26S proteasome of which mutations are reported in Parkinson disease patients (34), and knock-out of mice Rpt3 gene results in early-embryonic lethality (35).”
BackgroundThe ubiquitin proteasome system in neurodegenerative diseases: Culprit, accomplice or victim?
Dennissen, F. J. A., Kholod, N., & van Leeuwen, F. W. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.01.003 · Cited by 144
“regulatory particle in PD (Wahl et al., 2008).”
Role of ubiquitin–proteasome-mediated proteolysis in nervous system disease
Hegde, A. N., & Upadhya, S. C. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.07.006 · Cited by 96
“A connection between the proteasome and PD was also provided by a genetic study of German PD patients which found variations in intron 5 of a gene encoding the proteasome subunit S6 ATPase more frequently in early-onset PD patients relative to late-onset PD patients [190].”
Expanding the role of proteasome homeostasis in Parkinson’s disease: beyond protein breakdown
Bi, M., Du, X., Jiao, Q., Chen, X., & Jiang, H. F. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03441-0 · Cited by 99
Ebstein, F., Poli Harlowe, M. C., Studencka-Turski, M., & Krüger, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02756 · Cited by 79
“, PSMC3 and PSMD12) have been reported in the literature to carry genomic alterations causing diseases (30, 31) (Figure 1).”
BackgroundExploring the Role of Ubiquitin–Proteasome System in Parkinson's Disease
Behl, T., Kumar, S., Althafar, Z. M., Sehgal, A., Singh, S., Sharma, N., Badavath, V. N., Yadav, S., Bhatia, S., Al‐Harrasi, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02851-1 · Cited by 70
“Based on studies that proteasome component Rpt2 depletion promotes α-synuclein deposition and inclusions like Lewy body in mice, α-synuclein is established as a 26S proteasome's substrate [25, 62].”
BackgroundProteasome Subunits Involved in Neurodegenerative Diseases
Fernández-Cruz, I., & Reynaud, E. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.09.007 · Cited by 54
Failure of Ubiquitin Proteasome System: Risk for Neurodegenerative Diseases
Zheng, C., Geetha, T., & Babu, J. R. (2014) · Neurodegenerative Diseases · doi:10.1159/000367694 · Cited by 39
Ubiquitin-Proteasome System in Neurodegenerative Disorders
Croft, G. R. B. (2015) · Journal of Drug Metabolism & Toxicology · doi:10.4172/2157-7609.1000187 · Cited by 43
“Based on the reports that depletion of the proteasome subunit Rpt2 results in accumulation of α-synuclein and the development of Lewy body-like inclusions in mice [81-83], αsynuclein is identified as a substrate for the 26S proteasome.”
BackgroundProteostasis in neurodegenerative diseases
Kinger, S., Jagtap, Y. A., Kumar, P., Choudhary, A., Prasad, A., Prajapati, V. K., Kumar, A., Mehta, G., & Mishra, A. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.04.002 · Cited by 36
Rogers, N. K., Paine, S., Bedford, L. E., & Layfield, R. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01063.x · Cited by 35
Ubiquitin-Proteasome-Mediated Protein Degradation and Disorders of the Central Nervous System
Hegde, A. N., Timm, L. E., Sivley, C. J., Ramiyaramcharankarthic, S., Lowrimore, O. J., Hendrix, B. J., Grozdanov, T. G., & Anderson, W. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030966 · Cited by 19
Inducible Rpt3, a Proteasome Component, Knockout in Adult Skeletal Muscle Results in Muscle Atrophy
Kitajima, Y., Suzuki, N., Yoshioka, K., Izumi, R., Tateyama, M., Tashiro, Y., Takahashi, R., Aoki, M., & Ono, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00859 · Cited by 14
“It has been reported that muscle atrophy varies with muscle fiber type (Wang and Pessin, 2013).”
BackgroundRpt2 proteasome subunit reduction causes Parkinson's disease like symptoms in Drosophila
Fernández-Cruz, I., Sánchez-Díaz, I., Narváez‐Padilla, V., & Reynaud, E. (2020) · IBRO Reports · doi:10.1016/j.ibror.2020.07.001 · Cited by 16
Clearance Pathways for α‐Synuclein in Parkinson's Disease
Ho, M. S.-C. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70124 · Cited by 19
“…various proteasomal subunits—including Rpt2, Rpt3, Rpn11, or Rpn6—leads to the accumulation of misfolded proteins or Lewy body–like inclusions, accompanied by motor deficits characteristic of PD (Bedford et al. 2008; Pathare et al. 2012; Tashiro et al. 2012; Tonoki et al. 2009; Wahl et al. 2008).”
The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Proteostasis Factors
Creekmore, B. C., Chang, Y., & Lee, E. B. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab029 · Cited by 10
Protein clearance mechanisms and their demise in age-related neurodegenerative diseases
Sáez, I., & Vílchez, D. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.1.1 · Cited by 2
“Interestingly, variations in the gene PSMC4/Rpt3 correlate with the age of PD onset in patients [122], suggesting a role for the 26S/30S in α-synuclein degradation.”
BackgroundProteasomes in Autoinflammation
Brehm, A., Ebstein, F., & Krüger, E. (2019) · Springer eBooks · doi:10.1007/978-3-319-98605-0_7 · Cited by 3
Metadata
- Authors
- Wahl, C., Kautzmann, S., Krebiehl, G., Strauss, K., Woitalla, D., Müller, T., Bauer, P., Riess, O., & Krüger, R.
- Affiliations
- Hertie Institute for Clinical Brain Research (DE)
- Ruhr University Bochum (DE)
- St. Joseph-Krankenhaus (DE)
- University of Tübingen (DE)
- Corresponding author
- Krüger, Rejko
- Venue
- Journal of Neural Transmission
- Published
- 2008-04-30
- Volume
- 115
- Issue
- 8
- Pages
- 1141-1148
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2075222422
- Cited by
- 22
- References
- 31
- Citations by year
- 2025: 2 · 2024: 1 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 2 · 2015: 2 · 2014: 3 · 2013: 1 · 2012: 2
- FWCI
- 0.43
- Type
- journal article
- Language
- en
- Open access
- green
- orbilu.uni.lu
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, proteasome, protein degradation, synphilin-1, Parkin, alpha-synuclein, intronic variants, insertion-deletion variants, early-onset Parkinson's disease, familial Parkinson's disease, genetic susceptibility, German patients
- MeSH terms
- ATPases Associated with Diverse Cellular Activities, Adenosine Triphosphatases, Aged, Alleles, Carrier Proteins, Chromatography, High Pressure Liquid, DNA Mutational Analysis, Female, Genotype, Germany, Humans, Introns, Male, Middle Aged, Nerve Tissue Proteins, Parkinson Disease, Protein Denaturation, Polymorphism, Restriction Fragment Length, RNA, Messenger, DNA, Complementary, Reverse Transcriptase Polymerase Chain Reaction, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.